Shigehiro Koganemaru

6PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Toxicology (incl. clinical toxicology)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 16, 2024
The Tumor Immune Microenvironment and Therapeutic Efficacy of Trastuzumab Deruxtecan in Gastric Cancer.

Shigehiro Koganemaru, Shohei Koyama, Fumitaka Suto

|Oct 25, 2024
Potential Mechanisms of Interstitial Lung Disease Induced by Antibody-Drug Conjugates Based on Quantitative Analysis of Drug Distribution.

Shigehiro Koganemaru, Hirobumi Fuchigami, Chihiro Morizono

|Dec 23, 2023
Special Issue: Evaluation of the Antitumor Mechanism of Armed Antibodies.

Yoshikatsu Koga, Hiroki Takashima, Shigehiro Koganemaru

|Oct 07, 2023
Quantitative Analysis of the Concentration of Trifluridine in Tumor Hypoxic Regions Using a Novel Platform Combining Functional Endoscopy and Mass Spectrometry.

Shigehiro Koganemaru, Hirobumi Fuchigami, Hiroki Yamashita

|Mar 08, 2017
Prognostic value of programmed death-ligand 1 expression in patients with stage III colorectal cancer.

Shigehiro Koganemaru, Naoko Inoshita, Yuji Miura

Pageof 1